NEW ORLEANS, May 12, 2025 (GLOBE NEWSWIRE) -- The first-ever U.S.-based meeting of the World Astatine Community will take place June 19-20, 2025 at the Sheraton in downtown New Orleans. The event ...

Radiopharmaceutical experts and researchers to gather June 19-20 in New Orleans NEW ORLEANS, May 12, 2025 (GLOBE NEWSWIRE) -- The first-ever U.S.-based meeting of the World Astatine Community will ...

Astatine-211 is a promising alpha emitter for targeted alpha therapy for cancer, but astatine is among the least-studied elements. In this research, scientists investigated astatine’s ...

The science Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour half-life means that it must be handled quickly to minimize ...

Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to ...

Astatine is the rarest naturally occurring element on Earth and one of the least studied within the periodic table, mostly because it lives up to its name, which is the Greek word for "unstable." ...

Astatine‑211 is increasingly recognized as the alpha emitter of choice for targeted radiotherapeutics. Its pure alpha emission results in high‑energy, short‑range cytotoxicity that ...

Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to ...